Business● Low47m ago · Nov 16, 2026, 9:03 PM
BrainStorm Cell Therapeutics GAAP EPS of -$0.68 misses by $0.50
GlobeAlert Desk · curated from Seeking Alpha Tech · global
BrainStorm Cell Therapeutics reported GAAP EPS of -$0.68, missing expectations by $0.50. This is a routine financial update relevant for stakeholders monitoring the company's fiscal results.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business14m agoAssets of Ali Emre Ballı and İlkay Ballı seizedNTV · TürkiyeBusiness15m agoInstalled Building Products acquires Take Pride Insulation; adds $6M revenueSeeking Alpha TechBusiness16m agoNextBoat Inc. GAAP EPS of -$0.18, revenue of $50.6MSeeking Alpha TechBusiness17m agoEnvela GAAP EPS of $0.15 beats by $0.01, revenue of $43.44M misses by $8.57MSeeking Alpha Tech